EN
登录

默克与西门子深化战略合作,加速人工智能和数据驱动的药物发现与开发

Merck and Siemens deepen strategic partnership to accelerate AI and data-driven drug discovery and development

西门子 等信源发布 2025-09-23 15:15

可切换为仅中文


Siemens and Merck extend their strategic partnership: Jean-Charles Wirth, Member of the Executive Board and CEO Life Science, Merck and Cedrik Neike, Member of the Managing Board at Siemens AG and CEO of Siemens Digital Industries. Source Image: Merck

西门子和默克延长战略合作关系:默克执行董事会成员兼生命科学首席执行官Jean-Charles Wirth,以及西门子股份公司管理委员会成员、西门子数字工业首席执行官Cedrik Neike。来源图片:默克

“Through this collaboration with Siemens, we are opening new possibilities for scientists to move faster from an idea in the lab to a therapy for patients,” said Jean-Charles Wirth, Member of the Executive Board and CEO Life Science, Merck. “By combining our strengths, we aim to change how science advances, unlocking new ways to accelerate scientific progress.”.

“通过与西门子的合作,我们正在为科学家们开辟新的可能性,让他们能够更快地将实验室中的想法转化为患者的治疗方案,”默克公司执行董事会成员兼生命科学首席执行官Jean-Charles Wirth说道。“通过结合我们的优势,我们的目标是改变科学发展的进程,开创加速科学进步的新途径。”

“We are partnering with Merck to give scientists around the world the instruments to speed up the development of life-saving medication”, said Cedrik Neike, Member of the Managing Board at Siemens AG and CEO of Siemens Digital Industries. “Every few years the cost for developing a new drug is doubling.

“我们正在与默克公司合作,为世界各地的科学家提供仪器,以加快拯救生命的药物的研发,”西门子股份公司董事会成员兼西门子数字工业首席执行官Cedrik Neike说道。“每隔几年,开发一种新药的成本就会翻倍。”

Data, AI and digitalization are key to break this paradigm. We are connecting every step of drug development through a digital backbone – so that data flows seamlessly, insights emerge faster, and medication reaches the patients faster.”.

数据、人工智能和数字化是打破这一范式的 ключ。我们正在通过数字骨干网连接药物开发的每一个步骤,从而实现数据的无缝流动、洞察的快速产生,并加速药物送达患者手中。"

The collaboration will focus on digital-first solutions that close workflow gaps in drug discovery and biomanufacturing by integrating Merck’s software-as-a-service (SaaS) products with Siemens’ digital ecosystem. Initial pilot projects include making Merck’s AI tools and digital applications available in Luma, Siemens' Scientific Intelligence Platform acquired as part of Dotmatics.

该合作将专注于通过将默克的软件即服务 (SaaS) 产品与西门子的数字生态系统相集成,来填补药物发现和生物制造中的工作流程空白的数字化优先解决方案。初期试点项目包括在西门子的科学智能平台 Luma(作为 Dotmatics 收购的一部分)中提供默克的人工智能工具和数字应用程序。

This will give scientists a single environment that links product ordering with immediate access to the digital tools and insights they need to make faster, data-driven decisions..

这将为科学家提供一个单一的环境,将产品订购与他们所需数字工具和见解即时访问链接起来,以便更快地做出数据驱动的决策。

Building on these projects, Siemens and Merck will pursue additional joint projects and explore deeper integration over time. These initiatives include co-developing smarter data management tools and intuitive interfaces that make advanced processes easier for scientists to use. The partnership is also evaluating digital marketplaces that would give customers streamlined access to complementary technologies and services..

基于这些项目,西门子和默克将开展更多的联合项目,并随着时间的推移探索更深层次的整合。这些举措包括共同开发更智能的数据管理工具和直观的界面,使科学家更容易使用先进流程。该合作伙伴关系还在评估数字市场,这将为客户提供简化的途径以获取互补的技术和服务。

Together, Merck and Siemens see digital innovation as central to the future of life sciences. This partnership is designed to set a new standard for digital transformation, giving scientists and manufacturers the tools to deliver breakthroughs faster. It also builds on earlier MoUs between the two companies in smart manufacturing, reflecting a shared commitment to advancing innovation across the industry..

默克公司和西门子共同认为,数字创新是生命科学未来的核心。该合作伙伴关系旨在为数字化转型树立新标杆,为科学家和制造商提供加速突破性进展的工具。同时,这也延续了两家公司在智能制造业早期签署的合作备忘录,体现了双方推动全行业创新的共同承诺。